These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35477798)

  • 41. Detection, chemical analysis, and pharmacological characterization of dipyanone and other new synthetic opioids related to prescription drugs.
    Vandeputte MM; Walton SE; Shuda SA; Papsun DM; Krotulski AJ; Stove CP
    Anal Bioanal Chem; 2023 Sep; 415(21):5165-5180. PubMed ID: 37173408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elucidating the Gas-Phase Behavior of Nitazene Analog Protomers Using Structures for Lossless Ion Manipulations Ion Mobility-Orbitrap Mass Spectrometry.
    Hollerbach AL; Lin VS; Ibrahim YM; Ewing RG; Metz TO; Rodda KE
    J Am Soc Mass Spectrom; 2024 Jul; 35(7):1609-1621. PubMed ID: 38907730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238.
    Fogarty MF; Vandeputte MM; Krotulski AJ; Papsun D; Walton SE; Stove CP; Logan BK
    Arch Toxicol; 2022 Jun; 96(6):1701-1710. PubMed ID: 35275255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats.
    Hashimoto T; Saito Y; Yamada K; Hara N; Kirihara Y; Tsuchiya M
    Anesthesiology; 2006 Sep; 105(3):574-80. PubMed ID: 16931992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of the μ- and κ-opioid receptor activation by eight new synthetic opioids using the [
    Otte L; Wilde M; Auwärter V; Grafinger KE
    Drug Test Anal; 2022 Jul; 14(7):1187-1199. PubMed ID: 35142070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of N-pyrrolidino protonitazene in powders sold as heroin and associated with overdose clusters in Dublin and Cork, Ireland.
    Killoran S; McNamara S; Kavanagh P; O'Brien J; Lakes R
    Drug Test Anal; 2024 May; ():. PubMed ID: 38769669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.
    Grecksch G; Just S; Pierstorff C; Imhof AK; Glück L; Doll C; Lupp A; Becker A; Koch T; Stumm R; Höllt V; Schulz S
    J Neurosci; 2011 Sep; 31(39):13890-6. PubMed ID: 21957251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and Transporters.
    Torralva R; Eshleman AJ; Swanson TL; Schmachtenberg JL; Schutzer WE; Bloom SH; Wolfrum KM; Reed JF; Janowsky A
    J Pharmacol Exp Ther; 2020 Sep; 374(3):376-391. PubMed ID: 32513839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fentanyl and other New Psychoactive Synthetic Opioids. Challenges to Prevention and Treatment.
    Albores-García D; Cruz SL
    Rev Invest Clin; 2023; 75(3):93-104. PubMed ID: 37441771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-
    Puig S; Barker KE; Szott SR; Kann PT; Morris JS; Gutstein HB
    Mol Pharmacol; 2020 Oct; 98(4):487-496. PubMed ID: 32723769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors.
    Varshneya NB; Walentiny DM; Moisa LT; Walker TD; Akinfiresoye LR; Beardsley PM
    Pharmacol Biochem Behav; 2021 Sep; 208():173242. PubMed ID: 34302853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.
    Glück L; Loktev A; Moulédous L; Mollereau C; Law PY; Schulz S
    Biol Psychiatry; 2014 Nov; 76(10):767-74. PubMed ID: 24629717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nitazene test strips: a laboratory evaluation.
    De Vrieze LM; Stove CP; Vandeputte MM
    Harm Reduct J; 2024 Aug; 21(1):159. PubMed ID: 39198843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphans.
    Lutz JA; Sulima A; Gutman ES; Bow EW; Luo D; Kaska S; Prisinzano TE; Paronis CA; Bergman J; Imler GH; Kerr AT; Jacobson AE; Rice KC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metonitazene in the United States-Forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry.
    Krotulski AJ; Papsun DM; Walton SE; Logan BK
    Drug Test Anal; 2021 Oct; 13(10):1697-1711. PubMed ID: 34137194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
    Baker AK; Hoffmann VL; Meert TF
    Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacodynamics and pharmacokinetics of the novel synthetic opioid, U-47700, in male rats.
    Truver MT; Smith CR; Garibay N; Kopajtic TA; Swortwood MJ; Baumann MH
    Neuropharmacology; 2020 Oct; 177():108195. PubMed ID: 32533977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of tolerance and sensitization to different opioid agonists in rats.
    Grecksch G; Bartzsch K; Widera A; Becker A; Höllt V; Koch T
    Psychopharmacology (Berl); 2006 Jun; 186(2):177-84. PubMed ID: 16572262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Report on a novel emerging class of highly potent benzimidazole NPS opioids: Chemical and in vitro functional characterization of isotonitazene.
    Blanckaert P; Cannaert A; Van Uytfanghe K; Hulpia F; Deconinck E; Van Calenbergh S; Stove C
    Drug Test Anal; 2020 Apr; 12(4):422-430. PubMed ID: 31743619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.